RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 89-99
  • FDA Probes Liver Damage With Weight Loss Pill Alli

    FDA Probes Liver Damage With Weight Loss Pill Alli
    WASHINGTON -- The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency. Regulators said Monday they have received more than 30 reports of liver...
  • Experts: Swine Flu Vaccine Safe

    Experts: Swine Flu Vaccine Safe
    Untested? No. Rushed into production? Not really. Full of substances that do harm? Hardly, and especially not compared with the dangers of the H1N1 flu virus. That is the retort of researchers, scientists, federal health authorities and others familiar...
  • Ready to Quit Smoking?

    Ready to Quit Smoking?
    It's one instance where quitting isn't the easy way out. -------------------- FOR THE RECORD: Zyban: In Monday's Health section, an article on quitting smoking said that the smoking-cessation medication Zyban might act by blocking the brain chemicals...
  • Transcript of Gov. Rod Blagojevich's closing argument

    I'm grateful for the opportunity to be here today and present my closing argument and my chance to talk to you and talk to the people of Illinois and talk to anybody else who is listening. In the last couple of days I've had a chance to be able to go out...
  • Glaxo Settles Avandia Lawsuits for $460 Million

    Glaxo Settles Avandia Lawsuits for $460 Million
    GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said. Glaxo, the U.K.'s biggest drugmaker, agreed to...
  • The Avandia Dilemma

    The Avandia Dilemma
    The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...
  • For Diabetes Drug Avandia, Bad News Continues

    For Diabetes Drug Avandia, Bad News Continues
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
  • Experts Vote to Keep Avandia

    Experts Vote to Keep Avandia
    U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban. The 33-member panel of outside experts convened by the...
  • FDA: Avandia Should Stay With Restrictions

    FDA: Avandia Should Stay With Restrictions
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
  • Men taking erectile dysfunction drugs risk STDs

    Men taking erectile dysfunction drugs risk STDs
    Men who took erectile dysfunction drugs such as Viagra were more likely to become infected with sexually transmitted diseases, including AIDS, U.S. researchers have reported. This infection rate was higher even in the year before the men got their...
  • Glaxo Removing Zinc From Denture Cream

    Glaxo Removing Zinc From Denture Cream
    WASHINGTON (AP) - GlaxoSmithKline said Thursday it will remove zinc from its denture cream, following reports that excessive use over many years can cause neurological damage and blood problems in consumers. The British manufacturer will cease...